“CARDIOVASCULAR RISK PROFILES OF MONOTHERAPY VS. COMBINATION THERAPY IN TYPE 2 DIABETES”. 2025. Review Journal of Neurological & Medical Sciences Review 3 (7): 140-47. https://doi.org/10.63075/7swvcz45.